Market›Materials›Chemicals›Specialty Chemicals
BIOLARGO INC

BLGO

$0.15Apr 26, 2021 – Apr 24, 2026
MaterialsChemicalsSpecialty Chemicals$47M
MVM
-$0.8M
TD Variance
-2.500

Every news event mapped to its market reaction — 66 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2024-06-20-12.2%expansionSeeking AlphaBioLargo unit secures contract to provide air quality services
2024-06-20-12.2%earningsStock TitanBioLargo Engineering Increases Ongoing Revenue with Another Air Force Contract - Stock Titan
2024-04-03+11.1%earningsSeeking AlphaBioLargo reports Q4 results
2022-03-24-10.0%legalSEC EDGARBLGO 8-K: 1.01 and (SEC Filing)
2024-05-15-9.4%earningsSeeking AlphaBioLargo GAAP EPS of $0.00, revenue of $4.76M
2024-05-15-9.4%earningsSeeking AlphaBioLargo, Inc. (BLGO) Q1 2024 Earnings Call Transcript
2024-11-15-9.1%earningsSeeking AlphaBioLargo reports Q3 results
2022-11-16-7.6%earningsSeeking AlphaBioLargo, Inc. (BLGO) Q3 2022 Earnings Call Transcript
2024-06-24-7.5%earningsSeeking AlphaBioLargo, Inc. 2024 Q1 - Results - Earnings Call Presentation
2026-04-15-7.3%legalStock Titan[EFFECT] BIOLARGO, INC. SEC Filing - Stock Titan
2023-05-17-7.2%earningsSeeking AlphaBioLargo reports Q1 results
2026-04-01-7.1%executiveACCESS NewswireBioLargo CEO Dennis Calvert to Present Global Environmental Leadership Award to Robert Bilott at Nassau County PFAS Forum
2026-04-01-7.1%newsStock TitanDirector at Biolargo (BLGO) receives stock options as board pay - Stock Titan
2026-04-01-7.1%newsStock TitanBIOLARGO (BLGO) director receives 254,630 options as board compensation - Stock Titan
2026-04-01-7.1%newsStock TitanBIOLARGO (BLGO) director granted 92,593 stock options as $15,000 board fee - Stock Titan
2026-04-01-7.1%newsStock TitanBiolargo (BLGO) director Bray awarded 115,741-share stock option for board fees - Stock Titan
2026-04-01-7.1%newsStock TitanDark Waters lawyer Robert Bilott to receive award at New York PFAS forum - Stock Titan
2023-03-20-7.0%earningsSeeking AlphaBioLargo says Q1 revenues surpass previous record quarterly revenues
2026-03-21-6.9%legalStock TitanBLGO SEC Filings - Biolargo 10-K, 10-Q, 8-K Forms - Stock Titan
2023-11-21+6.1%earningsSeeking AlphaBioLargo, Inc. (BLGO) Q3 2023 Earnings Call Transcript
2025-11-18-5.8%legalSEC EDGARBLGO 8-K: 8.01 and (SEC Filing)
2022-06-30-5.8%newsSeeking AlphaBioLargo Engineering, Science & Technologies to help make novel nuclear reactor fuel production system
2026-02-09-5.8%legalACCESS NewswireBioLargo Subsidiary Clyra Medical Technologies Secures First Stocking Order with Advanced Solution for ViaCLYR(TM) Wound Irrigation Solution
2026-02-09-5.8%newsStock TitanNew wound wash with 72-hour germ kill begins US hospital rollout - Stock Titan
2026-03-04-5.7%earningsACCESS NewswireBioLargo Q4 2025 and Year End Earnings Results Webcast and Conference Call on Thursday, March 5th, 2026 - 12:00 PM Eastern Time
2025-08-13+5.5%earningsSeeking AlphaBioLargo reports Q2 results
2025-10-13+4.8%expansionSeeking AlphaBioLargo's Clyra Medical nears product launch, eyes global expansion in $732M wound care market
2026-03-25-4.6%legalSEC EDGARBLGO 8-K: 1.01, 3.02 (SEC Filing)
2026-03-25-4.6%newsStock TitanBioLargo (OTCQX: BLGO) arranges $10M flexible equity facility with Clearthink - Stock Titan
2022-11-03-4.6%legalSEC EDGARBLGO 8-K: 5.02, 7.01 (SEC Filing)
2024-01-22+4.5%earningsSeeking AlphaBioLargo reports 2023 revenues more than double 2022 revenues
2025-11-17-4.5%earningsSeeking AlphaBioLargo reports Q3 results
2024-08-06+3.8%earningsSeeking AlphaBioLargo reports Q2 results
2026-03-05-3.7%earningsGuruFocus.comBioLargo Inc (BLGO) Q4 2025 Earnings Call Highlights: Strategic Shifts and Financial Challenges
2026-03-05-3.7%analystACCESS NewswireBioLargo Reports Annual 2025 Operating and Financial Results
2026-03-05-3.7%newsSeeking AlphaBioLargo anticipates 2026 as a transformative year with Clyra Medical commercialization and battery joint ventures
2026-03-05-3.7%earningsSeeking AlphaBioLargo, Inc. (BLGO) Q4 2025 Earnings Call Transcript
2026-03-05-3.7%newsStock TitanSurgical wounds, clean water and batteries: inside BioLargo's tough 2025 - Stock Titan
2026-03-05-3.7%newsStock TitanBioLargo (OTCQX: BLGO) loses top client but grows new segments - Stock Titan
2023-01-31-2.5%earningsTMX NewsfileBioLargo, Inc. Discusses 125% Revenue Increase for 2022 with The Stock Day Podcast - TMX Newsfile
2024-08-14-2.0%earningsSeeking AlphaBioLargo, Inc. (BLGO) Q2 2024 Earnings Call Transcript
2022-03-08-1.9%legalSEC EDGARBLGO 8-K: 1.01 and (SEC Filing)
2022-11-29+1.8%analystTradingViewBLGO Forecast — Price Target — Prediction for 2027 - TradingView
2025-04-24+1.5%newsStock TitanBLGO Stock Price, News & Analysis - Stock Titan
2023-03-22+1.4%newsSeeking AlphaBioLargo buys battery tech and forms a new subsidiary
2026-04-17-1.0%M&AStock Titan30M shares reserved for resale; BioLargo (OTCQX: BLGO) Clearthink deal - Stock Titan
2025-11-15+0.9%earningsSeeking AlphaBioLargo, Inc. (BLGO) Q3 2025 Earnings Call Transcript
2025-04-01-0.9%earningsSeeking AlphaBioLargo, Inc. (BLGO) Q4 2024 Earnings Call Transcript
2026-04-20+0.9%expansionACCESS NewswireBioLargo Engineering, Science & Technologies Awarded $1.2 Million Contract to Design Pilot-Scale Minerals Processing Facility for Resource Recovery
2026-04-20+0.9%expansionStock TitanLegacy waste site moves toward reuse in $1.2M BioLargo contract - Stock Titan
2023-04-04+0.8%earningsSeeking AlphaBioLargo, Inc. (BLGO) Q4 2022 Earnings Results Conference Call Transcript
2021-05-19-0.8%legalSEC EDGARBLGO 8-K: 8.01 and (SEC Filing)
2023-08-17+0.7%earningsSeeking AlphaBioLargo reports Q2 results
2022-12-19+0.7%legalSEC EDGARBLGO 8-K: 1.01, 3.02 (SEC Filing)
2023-08-18-0.7%earningsSeeking AlphaBioLargo, Inc. (BLGO) Q2 2023 Earnings Call Transcript
2026-04-02-0.6%newsStock Titan[Form 4] BIOLARGO, INC. Insider Trading Activity - Stock Titan
2026-03-06+0.4%newsSeeking AlphaBioLargo reports FY results
2026-01-27-0.4%newsACCESS NewswireBioLargo Installs AEC PFAS Treatment System at Lake Stockholm, New Jersey
2026-01-27-0.4%newsStock TitanNew PFAS system targets cleaner drinking water for New Jersey lake town - Stock Titan
2023-11-15-0.3%earningsSeeking AlphaBioLargo reports Q3 results
2026-02-18-0.2%newsACCESS NewswireBioLargo Subsidiary Clyra Medical Highlights Key Opinion Leader Presentation of Exceptional ViaCLYR(TM) Clinical Results at Leading Wound Care Symposium
2023-04-03+0.2%earningsSeeking AlphaBioLargo GAAP EPS of -$0.02, revenue of $5.88M
2023-04-03+0.2%earningsSeeking AlphaBioLargo net loss of $5.13M, revenue of $5.88M
2022-11-15-0.1%earningsSeeking AlphaBioLargo GAAP EPS of $0.00, revenue of $1.5M
2023-03-27+0.0%legalSEC EDGARBLGO 8-K: 1.01 and (SEC Filing)
2026-04-25—legalStock TitanBLGO SEC Filings - Biolargo 10-K, 10-Q, 8-K Forms - Stock Titan
tickerdossier.comtickerdossier.substack.com